July 5, 2002
Emory Settles Patent Dispute Over AIDS Drugs
Emory University has settled a patent dispute with GlaxoSmithKline and Shire Pharmaceuticals Group over the rights to three promising anti-AIDS drugs. Financial terms were not disclosed, but Emory is likely to receive many millions of dollars in the years ahead.
Terms of the agreement, announced last month, stipulate that Emory will receive a license under Shire's patents related to emtricitabine, while Shire and GlaxoSmithKline will receive licenses under Emory's patents related to
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
